Cargando…
Gluten Immunogenic Peptides (GIP) Point-of-Care Urine Test in Coeliac Disease Follow-up before and during the COVID-19 Lockdown in Italy
INTRODUCTION: Celiac disease (CeD) diagnosis has worldwide shared protocols. Conversely, follow-up of patients is still an object of study. Gluten immunogenic peptide detection in the urine (GIP) appears to be a new and efficient method for dietary gluten control of patients. The present study aims...
Autores principales: | Ciacci, Carolina, Gagliardi, Mario, Siniscalchi, Monica, Ruotolo, Monica, Santonicola, Antonella, Hajji, Najla, Zingone, Fabiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605791/ https://www.ncbi.nlm.nih.gov/pubmed/34815686 http://dx.doi.org/10.2147/CEG.S326137 |
Ejemplares similares
-
Increased COVID-19 Lockdown Burden in Italian Adults with Gastrointestinal Diseases
por: Ruotolo, Monica, et al.
Publicado: (2021) -
Telemedicine in the COVID-19 era for Liver Transplant Recipients: an Italian lockdown area experience
por: Santonicola, Antonella, et al.
Publicado: (2021) -
Appetite and Gastrointestinal Hormone Response to a Gluten-Free Meal in Patients with Coeliac Disease
por: Vitaglione, Paola, et al.
Publicado: (2019) -
Quality-of-Life Evaluation in Coeliac Patients on a Gluten-Free Diet
por: Marsilio, Ilaria, et al.
Publicado: (2020) -
Coeliac disease: no difference in milk and dairy products consumption in comparison with controls
por: Zingone, Fabiana, et al.
Publicado: (2019)